STOCK TITAN

ClearOne (NASDAQ: CLRO) secures $1.75M equity deal with largest stockholder

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

ClearOne, Inc. entered into a private placement with its largest stockholder, First Finance Ltd., agreeing to sell 437,500 common shares at $4.00 each and issue a warrant for up to 437,500 additional shares at $5.00 per share. This transaction is expected to provide aggregate gross proceeds of $1,750,000.

The warrant runs for two years and becomes exercisable six months after issuance. ClearOne will initially access $500,000, with the remaining $1,250,000 available after it completes a reincorporation from Delaware to Nevada. The company also accepted limits on new debt over $10,000 and other material transactions without the purchaser’s consent, and committed to seek registration of the resale of the new shares and warrant shares on Form S-3 after its 2025 Form 10-K information is filed.

Positive

  • None.

Negative

  • None.

Insights

ClearOne secures $1.75M related‑party equity financing with conditional access and governance covenants.

ClearOne agreed to a private placement of 437,500 common shares at $4.00 plus a two‑year warrant for 437,500 shares at $5.00, for gross proceeds of $1,750,000. The purchaser is its single largest stockholder, indicating insider support for the financing structure.

Only $500,000 is immediately available, with the remaining $1,250,000 contingent on reincorporating from Delaware to Nevada. The company also accepted restrictions on incurring indebtedness above $10,000 and entering other material transactions without purchaser consent, which may limit financial and strategic flexibility while these terms apply.

The transaction is exempt from registration under Section 4(a)(2) and Rule 506(b), with a commitment to file a Form S‑3 resale registration after the 2025 Form 10‑K information is filed. Actual impact will depend on completion of the reincorporation and future warrant exercise within the two‑year term.

0000840715 false CLEARONE INC 00008407152026-03-052026-03-05



 


UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): March 5, 2026 (March 2, 2026)

 

ClearOne, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-33660

 

87-0398877

(State or Other Jurisdiction of Incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

5225 Wiley Post Way, Suite 500, Salt Lake City, Utah

 

84116

(Address of principal executive offices)

 

(Zip Code)

 

+1 (801) 975-7200

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communication pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240.13e-4©)


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).     Emerging growth company 


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 


Securities Registered Pursuant to Section 12(b) of the Act:  

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001

CLRO

The NASDAQ Capital Market





Item 1.01              Entry into a Material Definitive Agreement.

 

On March 2, 2026, ClearOne, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with First Finance Ltd., a California corporation (the “Purchaser”), pursuant to which the Company agreed to issue and sell, in a private placement 437,500 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $4.00 per share of Common Stock (the “Offering”), and a warrant (the “Warrant”) to purchase up to 437,500 shares of Common Stock (the “Warrant Shares” and, together with the Shares and Warrant, the “Securities”), for aggregate gross proceeds of $1,750,000 to the Company. The Warrant has an exercise price of $5.00 per share, a term of two years, and shall be exercisable six months from the date of issuance. The Purchaser is an affiliate of the Company and the Company’s single largest stockholder.

 

The Securities are not being registered under the Securities Act of 1933, as amended (the “Securities Act”), and were offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder.

 

Pursuant to the terms of a registration rights agreement dated March 2, 2026 by and among the Company and the Purchaser (the “Registration Rights Agreement”), the Company agreed to use best efforts to cause a registration statement on Form S-3 providing for the resale by the Purchaser of the Shares and Warrant Shares to become effective 90 calendar days following the date that the Company files with the SEC all of the information in its annual report on Form 10-K for the year ended December 31, 2025, including all of the information required by Part III of Form 10-K.


The Purchase Agreement contains customary representations and warranties and agreements of the Company and the Purchasers and customary indemnification rights and obligations of the parties. Pursuant to the terms of the Purchase Agreement, the Company will hold the proceeds of the Offering in a segregated bank account pending disbursement in accordance with the Purchase Agreement. $500,000 of the Offering proceeds will be immediately available to the Company, and the remaining $1,250,000 will become available to the Company upon the completion of a reincorporation of the Company from Delaware to Nevada. In addition, the Company has agreed to certain restrictions on the incurrence of indebtedness greater than $10,000 or the entry into any other material transactions without the consent of Purchaser.


The Offering is expected to close on or about March 6, 2026, subject to customary closing conditions.


The foregoing summaries of the Purchase Agreement, Registration Rights Agreement and Warrant do not purport to be complete and are subject to, and qualified in their entirety by, such documents attached as Exhibits 10.1, 10.2 and 4.1, respectively, to this Current Report on Form 8-K, which are incorporated herein by reference.


Item 3.02              Unregistered Sale of Equity Securities


The disclosure of the Offering under Item 1.01 above is incorporate herein by reference.

Item 9.01              Financial Statements and Exhibits

(d)  Exhibits 

Exhibit Number

 

Exhibit Title

4.1
Form of Warrant.

10.1*

 

Securities Purchase Agreement.

10.2

 

Registration Rights Agreement.

104.1
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.


* Schedules and Exhibits have been omitted pursuant to Item 601(a)(5) Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules and exhibits upon request by the SEC.



SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CLEARONE, INC.

 

 

 

Date: March 5, 2026

By:

/s/ Simon Brewer

 

 

Simon Brewer

 

 

Chief Financial Officer

 

FAQ

What financing transaction did ClearOne (CLRO) enter into on March 2, 2026?

ClearOne entered a Securities Purchase Agreement to privately place 437,500 common shares at $4.00 each and a warrant for up to 437,500 additional shares at $5.00, providing aggregate gross proceeds of $1,750,000 to the company from its largest stockholder.

How is the $1,750,000 in proceeds from ClearOne’s private placement structured?

ClearOne will hold the $1,750,000 in a segregated bank account. Of this, $500,000 is immediately available, while the remaining $1,250,000 becomes available only after the company completes a reincorporation from Delaware to Nevada, as specified in the purchase agreement.

What are the key terms of the warrant issued by ClearOne (CLRO) in this deal?

The warrant allows purchase of up to 437,500 ClearOne common shares at an exercise price of $5.00 per share. It has a two‑year term and becomes exercisable six months after the date of issuance, providing potential additional equity funding if exercised.

Who is the purchaser in ClearOne’s March 2026 private placement?

The purchaser is First Finance Ltd., a California corporation that is an affiliate of ClearOne and the company’s single largest stockholder. This insider participation suggests internal support, while also creating a related‑party transaction governed by detailed agreements and restrictions.

What restrictions did ClearOne agree to under the Securities Purchase Agreement?

ClearOne agreed to restrictions on incurring indebtedness greater than $10,000 and on entering other material transactions without the purchaser’s consent. These covenants apply alongside customary representations, warranties, and indemnification provisions contained in the Securities Purchase Agreement.

How will ClearOne handle registration of the shares and warrant shares from this offering?

Under a Registration Rights Agreement, ClearOne will use best efforts to make a Form S‑3 registration statement for resale of the shares and warrant shares effective 90 days after it files all required 2025 Form 10‑K information with the SEC, including Part III disclosures.

Under what securities law exemption was ClearOne’s March 2026 offering conducted?

The offering was not registered under the Securities Act of 1933. It relied on the exemption provided by Section 4(a)(2) and Rule 506(b), which permit certain private placements to accredited or sophisticated investors without a public registration statement.

Filing Exhibits & Attachments

8 documents
Clearone Inc

NASDAQ:CLRO

View CLRO Stock Overview

CLRO Rankings

CLRO Latest News

CLRO Latest SEC Filings

CLRO Stock Data

9.31M
867.80k
Communication Equipment
Telephone & Telegraph Apparatus
Link
United States
SALT LAKE CITY